Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Alnylam Pharmaceuticals Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Alnylam Pharmaceuticals Inc tiene un total de activos de $4,239, una ganancia neta loss de $-278

Question 2

¿Cuáles son los ratios financieros clave para ALNY?

Accepted Answer

El ratio corriente de Alnylam Pharmaceuticals Inc es 1.01, el margen neto es -12.36, las ventas por acción son $17.61.

Question 3

¿Cómo se desglosan los ingresos de Alnylam Pharmaceuticals Inc por segmento o geografía?

Accepted Answer

Currently Alnylam Pharmaceuticals Inc data is not available.

Question 4

¿Es rentable Alnylam Pharmaceuticals Inc?

Accepted Answer

no, según los últimos estados financieros, Alnylam Pharmaceuticals Inc tiene una ganancia neta loss de $-278

Question 5

¿Tiene Alnylam Pharmaceuticals Inc alguna deuda?

Accepted Answer

yes, Alnylam Pharmaceuticals Inc tiene una deuda de 4,172

Question 6

¿Cuántas acciones en circulación tiene Alnylam Pharmaceuticals Inc?

Accepted Answer

Alnylam Pharmaceuticals Inc tiene un total de acciones en circulación de 129.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,461	2,248	1,828	1,037	844	492
Revenue Growth (YoY)	5%	23%	76%	23%	72%	125%
Cost of Revenue	402	323	310	168	140	78
Gross Profit	2,059	1,924	1,517	868	704	414
Selling, General & Admin	1,079	975	795	770	620	588
Research & Development	1,159	1,126	1,004	883	792	654
Operating Expenses	2,239	2,101	1,800	1,653	1,412	1,243
Other Non Operating Income (Expenses)	18	-6	-17	-6	-19	45
Pretax Income	-379	-377	-433	-1,127	-852	-855
Income Tax Expense	-60	-99	6	4	0	2
Net Income	-319	-278	-440	-1,131	-852	-858
Net Income Growth	343%	-37%	-61%	33%	-1%	-3%
Shares Outstanding (Diluted)	130.62	127.65	124.9	121.7	118.5	115
Shares Change (YoY)	3%	2%	3%	3%	3%	5%
EPS (Diluted)	-2.44	-2.17	-3.52	-9.3	-7.2	-7.46
EPS Growth	328%	-38%	-62%	28.99%	-3%	-8%
Free Cash Flow	-52	-42	41	-613	-718	-685
Free Cash Flow Per Share	-0.39	-0.32	0.32	-5.03	-6.05	-5.95
Gross Margin	83.66%	85.58%	82.98%	83.7%	83.41%	84.14%
Operating Margin	-7.31%	-7.82%	-15.42%	-75.69%	-83.88%	-168.29%
Profit Margin	-12.96%	-12.36%	-24.07%	-109.06%	-100.94%	-174.39%
Free Cash Flow Margin	-2.11%	-1.86%	2.24%	-59.11%	-85.07%	-139.22%
EBITDA	-124	-120	-228	-741	-661	-794
EBITDA Margin	-5.03%	-5.33%	-12.47%	-71.45%	-78.31%	-161.38%
D&A For EBITDA	56	56	54	44	47	34
EBIT	-180	-176	-282	-785	-708	-828
EBIT Margin	-7.31%	-7.82%	-15.42%	-75.69%	-83.88%	-168.29%
Effective Tax Rate	15.83%	26.25%	-1.38%	-0.35%	0%	-0.23%

Alnylam Pharmaceuticals Inc (ALNY) Price